Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed. BBC and Nature and JAMA results are unprecedented.
Since I am not here all that much these days and I do not post much but responses to bashers generally, that would not make me a “paid pumper” by any stretch of the imagination. But apparently that is the only short argument you have, other than that a simple procedure like leukapherisis is going to be a long-term barrier to entry…. lol.
Your choice. They will fill the board and, if you leave all of the detritus about it chokes a board with false narratives and then what sound like pumps in contrast. Random people often do not know who is who or what their motives are.
I am not here that much. I pop in and dispel the regular BS’ers not because I believe regulars believe them. Though in some cases, people end up later repeating arguments that are bogus because they were left or given some degree of legitimacy through neglect.
I did not say it “sells itself”, they already have numerous cancer centers from the trial. This treatment is very specialized, so the professionals and centers that need to be brought in initially can be key centers in key cities.
Additionally there is no other treatment that has had this result that is systemic. You seem to think this is a highly competitive space where there are numerous treatments and they will need to compete for attention. Without media, I would bet that most doctors performing brain surgery in these key countries and key research centers know about this treatment. This is a rare disease, not common.
And we know that patients with obscure cancers from places not where these trials took place, have sought this treatment out, despite there being no trials with it in their obscure diseases.
I’m further, confident that they can find deals if they need them for marketing, when the time comes. I’m not here to falsely panic people, as you are, which we know from the bulk and content of your every post. I am an investor, and I actually believe what I post. The disingenuous are here too, and they do not disclose their interests or disclose it in a fashion that suggests they are being other than truthful.
Yeah, though he never had a chance as he did not have a tumor. I believe he claims he had an infection, which then he claimed showed how incompetent KC really is, but it sounds like they likely just did an initial assessment and likely wanted to know more.
When John McCain had his surgery, I believe they did not know what he had until they went in, and were surprised. Who knows what really happened here but it has nothing to do with any of us or NWBO. He’s confused.
NWBO is not Funding it and yes, when you pay for it at their facilities, they set-up a line and do the work and it is likely highly proprietary.
As for Advent, they are leasing space from NWBO, with a contract for services that is subject to cancellation at will with a years transition period for them to license themselves. NWBO owns Flaskworks entirely. It is their proprietary technology and development of those facilities can involve a service provider or not, in NWBO facilities, which is what Sawston is.
You can convolute things. Shorts do that. You seem to be on a little tirade here, but the reality is, it’s actually quite a beneficial and risk averse strategy, unless you want to posit things that are fundamentally not actually true.
I think you’re a bit confused.
So first of all, beyond confusing that shareholders that post on this board are “the company”, we’re not; you have secondly, further confused that NWBO is King’s College’s “commercial enterprise”… It’s not. King’s College is nowhere shown to be an owner of equity in this company or its IP. So your stalking King’s College (KC) by annoying shareholders here, is a wasted effort on your part.
Secondly, it sounds more like there was an initial identification of something on your brain scan, done when you had symptoms that might coincide with a brain tumor and then you got a second scan and a second opinion and found out you had an infection. It does not appear that KC interfered with your ability to get treated elsewhere, but it does sound like you somehow became obsessed with them and saw some news about their work on this trial and now you’re stalking us in lieu of stalking them, as I guessed earlier. Perhaps this is because you have been banned from stalking them directly…I have no idea, but it would explain your seeking out alternatives to bursting into patient changing rooms at King’s College… again, I am speculating on likely behavior, given your behavior and ideas here… Given the above, your time here, wasting all of our time with your imaginative stories about your imagined investigation, and KC wanting to both use your “survival” for their benefit and kill you… it seems like you’re a bit off kilter and need help, rather than a sane person giving opinions, even though at times, you’re quite cogent in your posts… which is, as I know from family with brain injury, is a thing. Paranoia is also a thing for brain injuries. It’s a symptom. Patients can function, but can be quite paranoid.
You were never part of this trial, never considered for it, because you were not a brain cancer patient and did not have your surgery, because, as you once clarified, you had an infection. Perhaps initially in discussions, you wanted to talk about possibilities and perhaps to keep you from freaking out if you had a brain tumor, you discussed what that would entail with a doctor at KC and they mentioned amazing results and tried to give you hope. That happens when patients get potentially devastating initial / tentative newsof such a possible diagnosis.
The idea that KC wanted to kill you takes your posts from sounding somewhat cogent to flying over the cuckoo’s nest. I suspect that somewhere inside, you know this too. My relative with the brain injury both knows when he is being nuts and still does it. That happens, and people rely on loved ones to keep them sane. Posting here is likely a hidden self-indulgence.
I doubt KC would substantiate anything you say and you and I know that patient records are always confidential anyway. You’re a silly character, no doubt but brain injuries can do that to people and once again, I encourage you to see a doctor.
I am not ridiculing you, but I am trying to keep your claims grounded in reality. I would rather see you get the care you need rather than stalking all of us, to prove that King’s College wants to kill you and contradictorily, wanted you in the clinical trial because you would not die because you did not have a brain tumor.
You see what you did there?
There are lines and different businesses with different risks and profiles. These businesses stand alone potentially and NWBO thus does not have to be in those particular businesses. It is perfectly fine and normal not to have those businesses and small companies use external contract manufacturers typically now, to avoid massive burn rates up front in development.
NWBO owns instead, Flaskworks, and Sawston. So all of the necessary infrastructure is available to bring it all in-house as they decide, when that makes sense for an operating company that wants to have all of that staff, not sitting idle, or working on some other company’s products, but doing the business that THIS company is in…
This argument by shorts that makes nonsense of lines of business and different businesses as if they are the same business, is ridiculous. Yes, it is a cost of getting through trials to manufacture a very discrete set of doses. Having the full, commercial and CGMP facilities from the start of Phase 1, used to bankrupt biologic companies. Hence the evolution of CDMOs.
I am an investor. The treatment extends life for patients generally and some with fantastic results. It is the first systemic treatment to do that in decades and it does so with minimal to no side-effects.
You can pretend you “know” something, even though you clearly do not, you can talk to investors like we are managing the company, which shows a complete lack of understanding and comprehension, you can pretend, falsely to be connected with “law enforcement” or to be some sort of bizarre mix of government official, former military, investigator and non-patient whistleblowers, but the reality is, nothing you say holds together and you seem genuinely confused, though articulate. I would presume you have some sort of deficit as a result of a likely brain injury, and I think you need help, and that every post here is literally a scream for help, because you are both confused but also certain you know stuff you clearly do not know.
I hope you’ll check in with a therapist or doctor.
Oh right, because you believe that you’re in super top secret ex parte communications with the UK regulator about the application for commercial marketing based on your claimed experience with Kings College, even though at no time were you ever part of or even considered for this trial, and you never actually had a brain tumor, though you’re still annoyed at King’s College for showing you your initial scans that showed something that might be the cause of your symptoms at the time and that it might be a brain tumor… if some sort, undetermined at that time, though it ultimately turned out to be something like an infection…
Cognate is licensed in the UK and this is compassionate use in the UK under the specials program, so all monies must have go through them. There is no approval to market or sell DCVax-L for NWBO. And while I have no idea how many patients have been a part of the recent compassionate use program, or how much they have paid up front, I do expect that those funds have been handy in meeting cash obligations for Cognate to be able to provide this service for now. Effectively they are licensed to and maintain a fully licensed facility for commercial manufacturing prior to approval for marketing. That typically is quite expensive. It’s one of the reasons scaling slowly and as appropriate and using the regional financing and providing services to other regional companies and researchers was such a perfect symbiotic approach to scaling as opposed to the previous model of this by Dendreon, who built hundreds of millions of dollars worth of localized facilities, on their own spreadsheet, in different places, a few years before approval only then to have approval delayed and to have those costs for years. LP has contained the risk and issues and yet developed a cutting edge facility for when NWBO goes commercial.
Except you have absolutely nothing to offer in terms of insights and no experience or knowledge of the company or drug. In fact, your claim that you had a brain tumor and went to King’s College was subsequently contradicted when you later said that the reason you basically stalk and hate King’s College is because a subsequent scan revealed you just had an infection.
You were never part of nor were you ever considered for any aspect of this trial or any other trial. Your presence here is all about your need for attention and I expect that you have been banned from King’s College for likely stalking people there. This is the easy route to creating trouble, you falsely believe, but we have no connection to King’s College or your initial, cautious diagnosis that required confirmation and which turned out NOT to be a brain tumor.
Or have you changed your story?
There is blood on their hands.
You’re an anonymous stalker fantasist. You make up stories every other day, left and right and you’re powerfully delusional. People should feel pity for you but you’re an attention seeking hound here only because you misguidedly feel you can further your mentally worrisome stalking of King’s College by posting nonsense here and annoying shareholders in this company, in a company that had absolutely no connection to you in any context, but which you initially implied, did.
Please get mental help.
Most of the time, in fact, in my experience, ASM’s for small bios are actually not broadcast. You end up either going or hearing detailed notes from others afterwards. The pandemic did change things a little, but not entirely.
And there you go again. So mature.
Yeah, you have nothing at stake here… nope, just out of the “goodness of your heart”…
Whatever. You’re not really saying anything at this point. You might take your own advice.
Thanks for your input. I’d say basically then you really have no real knowledge of this one, assuming you just came to comment out of the goodness of your heart. Thanks for your opinion. It’s not “emotion”, but we deal with a lot of shorts who constantly lie and say basically the same crap.
Your commentary on early “pricing” is understood as a part of startup microcap biotechs. Dilution is a necessary part of the process of going from nothing to the application process, so yeah, you’re bound to have very few shares and when you look back you’re going to see what looks like absurd pricing when they had a few tens of thousands of shares. And you’re going to see strange volatility, so the kinds of arguments you make might look like they make sense to a newby, but retail who know the space, don’t buy and hold at those early stages, because they understand that dilution is a necessary evil, as is volatility.
Doubtful you have much experience in these with that kind of commentary, and sounds like a typical short. Unfortunately, I have little time to address properly or fully your noise. But nothing you said actually addresses the opportunity here, it’s just opinion and you clearly don’t know the space. I am neither claiming that this is going to $100 any time soon or skyrocketing. It will likely continue to move along and likely, IMHO, get approval and have ups and downs until some deals are struck. But there is no denying that this is an incredible treatment and at some point I and many investors believe that it will not be ignored at that point. It appears to be a critical and basic piece to add to immunotherapies. And they have a particular opportunity that is not easily replicated elsewhere.
You’re welcome to your opinion, but why bother to come here and spend time posting if you have no stake. Why post the same old noise… seems like you’re part of a group or, an ID that posts here otherwise and simply does not want to connect the 2nd ID with the crappy ID used on this board…
This is a very narrow disease. They are not marketing to consumers. Doctors in very specific hospitals will be trained to do this and they already had many doctors and hospitals in their trial.
The reality is, you can only take in patients whose doctors do this specific surgery and then provide the tissue. So it is likely they will have already made headway with key hospitals in the UK, and the real issue will first be getting NICE approval. Dendreon scaled up and then they had delays and ended up spending many hundreds of millions they did not have, years before they needed to spend it.
So yeah, if they followed that pathway, they’d be criticized for that, but the reality is, there is not immense competition in brain cancer against them. They likely already have a very good idea of which doctors and hospitals and they don’t need staff going around “giving out samples” or plotting vacations for doctors to sell medicine that doesn’t work, but that can make a lot of money nonetheless. This treatment extends survival, as a systemic treatment, unlike anything else out there in decades.
So I think your post is basically from a know nothing, complaining about things you do not know or understand. Further, I think they can also do deals for that as well. So remaining flexible and keeping their burn rate as reasonable as possible at this stage is likely a good strategy for this company with this drug focusing on this disease. But yeah, if they were selling a cholesterol drug, things would be different.
And no. Never been paid by anyone and no, I do not pump. You’re full of crap and that is well known. And you’re not a real commentator. You just dropped in here to bash.
I think that number is over the life of the trials as compassionate use, not in recent times.
As for monies that come in for UK Specials program, my research says that NWBO can’t get that money, but rather it is paid only to a licensed compounding company locally licensed to provide it, not because the company chooses that arrangement but because that is how that program works. Now the company may have worked out that any such funds will pay down previously billed work for validating Flaskworks and expanding Sawston as well as production and that might be substantial amounts as well as potentially paying down local debt for the expansion of Sawston. It is worth asking, but I suspect they can’t really talk too much about it because they are not, as of yet, commercially licensed and likely the MHRA wants absolutely no commercial promotion of this until they are, in fact, licensed. But I doubt there is some immense amount of income they are hiding or misdirecting. That is short talk, but highly unlikely. Shorts love to make such claims, but there is nothing particular about Advent “being private” that would make “hiding income” easier unless you’re literally going to claim FRAUD. And if you’re claiming FRAUD, you’re not really making a long argument but “just curious”… it’s beyond that.
Given LP’s and Les’ backgrounds and positions as well as that this is a public company, while anything is always possible, in my estimation, the notion that this is some giant fraud is ludicrous and fever dream territory. Doubtful Linda Liau would have joined the SAB in that context, and I do not doubt that she likely knows basic details about matters such as that.
I kind of doubt they have had huge income because self-financing is not an easy ask. If it was covered, I believe they would have no problem with demand, but compassionate use has ALWAYS been a problematic category for all of these companies because these treatments are expensive when out of pocket and typically quite out of reach for most patients facing such devastating diseases.
Developing new technologies and taking them to market can take a decade to two or more. That’s just a reality. This was a very challenging trial made much more difficult by incessant shorts like the posters on this board, some of whom pretend to be “investors”, but are shorts.
Honestly, you have the right to your opinion. It doesn’t mean many won’t very vigorously disagree with you for numerous reasons not the least that at a time like this with small
Companies like this, such sentiment can destroy companies and therefore is usually the focus of shorts who do so with abandon.
As for the potential of the technology and where it is, it would be ridiculous to and futile to suddenly dump management. The fact is, NO ONE is ASKING you to “give management the benefit of the doubt.” You simply don’t need to be invested. Why would you invest in a company that you feel that way about when tomorrow you could buy into any number of new companies and start with a management team YOU like?
The purpose of such posts, in my opinion, has very little to do with reform and much more to do with shorting and profiting from it. But again, your opinion. Hope you find an investment you like rather than bothering current investors here. Good luck!
I would guess that you are simply an alternative ID of a short here and this is your Anavex ID, which you used, in typical puppetry fashion, to agree with yourself.
Given the survival results, your prediction seems highly unlikely for a disease like this. IMHO.
Even now, your claim about commercialization seems flawed. They cannot commercialize it at the moment, and yet here they are, approved for compassionate use with a commercial factory in the UK that can deliver to anywhere in the world. You misread the facts because either you’ve swallowed misinformation, hook line and sinker, or you do not understand how the UK Specials program works.
NWBO is not licensed to sell DCVax-L commercially in the UK at this time and the entity that makes the drug, can only do it on behalf of doctor and patient, of course, with the explicit permission of NWBO because they actually are licensed in the UK to do so. The arrangement by MHRA is also intended not to communicate that the drug is commercially available, because it isn’t, and yet, it is, without a doubt, a spectacular arrangement suggesting confidence in the value of the drug by both doctors that prescribe it and the regulator that facilitates the arrangement with full knowledge. It was even funded by a regional development authority. That is not going to be encouraged if they and the regulator are not feeling quite confident in the drug becoming a commercial product in the UK.
As for scaling up, it is also very possible that they will do a deal to scale up more quickly when the time comes. They have Flaskworks machines in the works, pending approval, and it appears that Roswell Park, which has funding for its own manufacturing facility. I expect the confidence to do a deal with NWBO did not just materialize for any one reason, though there are singular good reasons. They see the opportunity to commercialize their technologies and they see NWBO as a company that they would trust to do it.
They have far more at stake than any of us, and their knowledge is likely far more detailed as to what that will take.
So I’m going to look at that range of circumstances above any one anonymous opinion on the bulletin boards from someone who basically always posts negative or short posts.
Exactly. The board is great for chatting about and evaluating ideas and views and I expect even some longs have in different contexts believed many different things only to later realize that someone else’s articulated view that they may have, at the time, not agreed with, turned out to be a better view. No one is going to get it all right though many will have strong opinions and theories.
There are people one may have strong intuition, are not longs and are more traders. They might not even agree on the characterization even if it is, more likely true. People may see themselves through a filter as well. And being a trader does not invalidate a view entirely, it is just the blatantly manipulative posts I react to and sometimes it is the people who post wild ideas as well on the positive side because that too, can undermine confidence when people make claims that others come to believe are somehow part of a real bit of info from the company, and then they turn out to be pure fantasy.
Recognizing the difference between opinion and fact, as well, is helpful. Pointing out opinion, when it is presented as fact, is also a large part of the discussion, especially when one suspects or believes that a poster is intentionally disguising their position and motives or hiding them. And sometimes when opinion is presented as fact and becomes a bit self-delusional.
But there are many who are solid, despite a difference of opinion, here or there, and you know (or feel you know) they are speaking their belief truthfully. They may have a strong opinion, but recognize it as such. Those exchanges are very valuable over time.
I honestly have dug in on the cost issue for NICE and given the results and the benefits as well as that it’s not an ongoing cost but an up front cost for treatments that can go up to 3 years in a batch, the current costs we know of are reasonable for NICE. As for volume, they have not developed the full potential of Sawston even for manual manufacturing, they have it in stages.
I have never believed the manual manufacturing was the reason for delay, though I do believe they want to have Flaskworks in the approval process when they are getting approved because that is the best time to get their update for commercialization of manufacturing approved. I do not believe the entire process is dependent upon that for either MHRA or NICE though. In fact, my research suggested they could get premium pricing above and beyond current pricing based on results from both their trial and as seen in their Nature article except that poly-iclc is not yet approved. So I do think the poly-iclc delay is not ideal, but it may be possible for that to be expedited by Oncovir if they want. I would really be curious about any efforts and work between the companies to do that.
Kabunushi is a valued commentator and even when I don’t agree with him I always find his comments thoughtful and refreshing.
I do not doubt that Roswell’s new deal with the company is going to be a major pivoting event and I do not think the company would have entered into that deal without a plan. I agree they will need to also focus on commercialization. They can’t stay a development stage company forever. That would be very frustrating to us all.
I do believe they likely have a plan and I have been surprised and impressed each time they take a new turn whether buying Flaskworks or now this deal with Roswell. But I do agree that they need to focus on commercialization.
My research on Roswell’s developing technologies suggest there is some major gold in there yet to be discovered or even widely discussed here yet. I can’t claim to know if they are focused on all the things I found but if they develop good relations and if they are true to their PR, then there are some amazing relationships to develop there and potential technologies to bring to market, including technologies that I think would change perceptions of NWBO permanently.
But in the meantime, they need to have resources and commercialize properly.
I also like Bright Boy and Donny disagree at all with his enthusiasm on Roswell, as I suggest above. We all get a little touchy. Hope this helps.
I doubt that is a good way to invest, and many shareholders who were hurt may no longer own shares by that time. Let’s leave that up to them how to use those funds. Investing it into the company, is probably the best use, but which could be that or another use.
They had issues because some people did not understand or care that they had technology to create embryonic stem cell lines without destroying any embryos. That crowd did not care. And so their top scientist, who was a phenomenon in the space and had an immense amount of patents in the field of cell therapies and stem cells and cloning and induced pluripotent technologies and cell programming, was stalked by that crazy crowd and the government, while promising to open up the field of stem cell science, really did not do what everyone expected at the time. And then IPS or induced pluripotent stem cells became the rage, but they were defective at that time. Some people including the top scientist at Ocata, figured out ways to reprogram without using oncogenes (cancer genes), but the initial cells were all created basically by mutating normal cells and turning them into almost cancer cells or mutant cells. But the mania over avoiding pristine embryonic cells was so intense that it was basically irrational.
Jhamm was just a minor poster like anyone here. Not someone important ever. He only got any importance when he made this huge stink and HE organized a splinter board. And this website is a "private" message board. I did not create it nor do I own it. Neither did I own or create the Ocata board that was used. I went to the message boards for the stock I have always said I invested, in Ocata. I have never hidden that detail. I have been interested in cell therapies for many years. So no, you really are not saying anything new and NO there was never a board called biosectinvest. I never had such a board. There have been people who have copied the name from time to time. I did not leave his message board to form my own. In fact, you have it backwards. There was an Ocata board where many people participated. Jhamm fell out with the entire lot, like those calling everyone here "a cult" and formed his own board and took a small contingent along. A few of us may have popped over there from time to time to see what they were saying, because we were surprised at his turn. But you have the details mixed up.
I momentarily did suggest people set-up a google board as well, because as I recall, the board they were using was either not continuing or had issues. But someone organized a main board for Ocata, and that's where we were and stayed. I never was a major host or manager of a board. I might have suggested things like I would here, but your imagination has you going all over the place in terms of my importance or my leadership. I did not want to host a board particularly. All I wanted was for the other longs to have a place where they could possibly keep shorts from monopolizing the conversation, and as I said, someone, not me, ultimately organized an Ocata specific website that we aggregated to once we got past some weirdness. I actually think we started on the Yahoo board, but then Yahoo made some major change to the boards and we momentarily looked at and discussed a variety of possible options on google, which again, would not be my board, and then, as I said, someone organized a better option with actual bulletin board software on a private website, over which I had no control, though I do recall the software being better than the software here as you could have conversations on a thread so that any specific topic could be organized. This board is about maximizing posts and ad views. So it's not organized particularly well from a bulletin board / software perspective, in my opinion. It's to generate revenue for the owner.
And biosect investor is not unique. And as I said, I had some weird copycats over the years and still get some, from time to time. Stalker weirdos.
JHamm, was one of those initial overly enthused longs who then became a short. I did not know him personally. And I did not organize the boards, but I did join them. He got so negative at some point that he took his crowd and created another board.
I did alright in Ocata and yes, I rolled some of that money here. Some into FATE before it took off, and sold before it collapsed
Though I did not get all of the crazy ride there. Some into KITE and other companies.
As for “admissions”, no, your allegations get weird. I did appreciate the Ocata longs though. There were a lot of great folks over there. As also here.
Yeah there are a lot of swing traders in stocks like this. When you go to the annual, I won’t be there, you may think you’re talking to all longs, but I guarantee that some will be pretending, will have names you are familiar with and think are longs, but they are really swing traders and have multiple identities. Seen it before.
It’s one of the reasons I am very careful, even with effusively nice and complimentary people who approach. I learned my lesson a long time ago, that this lot is very bad, these shorts and swing traders and you need to be careful. Some of our fellow longs here have learned the hard way, getting stalked and people posting their personal business and details online just to intimidate them and shut them up. Some of the shorts are not far from gangsters and criminals, if far at all.
That would be great, but more likely for a growth company is the return should be higher investing in the product and more sales.
You say, by admission:
For everyone. The company is the point. Salaries and share allocations have nothing to do with setting the stage of the company from pre-revenue / pre-commercial to having an approved for marketing, commercial product. Again, a ridiculous comment.
True. But as we saw with Elon Musk, sometimes you can claim it was not fully disclosed and that’s what those who brought suit claimed. Unlike the case with Musk, that case is still not resolved, and is just a claim still being litigated. In pursuit of the most cautious approach, the company deferred the allocation until this second vote. It would be difficult at this time to claim no one knows, but I have no doubt people will try.
I agree that after this vote, the issue should be moot, but these guys mostly are trying to get a settlement and keep the company from being clear of any lawsuits and messing with the share uncertainty. I honestly think they have been glad to delay resolution because their purpose is to undermine. I do not believe they care, in truth, one way or the other about the issue. But that’s just my personal opinion.
No, I did not, though I do recall JHamm as an infiltrator and short from the days of Ocata, ACTC, which I have talked about before. But I did not have a private group for Ocata. There was one set-up by a group of investors that I joined not unlike this bulletin board and then another person created a separate website and we all went there. jHamm was a part of a breakaway group just like we see here when people go to another site that will remain nameless.
So I know this thing where you claim to go aha! Is like some sort of weird behavior by you. I was a long in Ocata, as here. I came out ahead in Ocata because I averaged down. Did not love the buyout. The patent portfolio alone there should have been worth more, but in the other hand, they also were a long ride and I was glad to move on at the end of the day given the strangeness of the shorts.
I have always been clear too that I like these amazing science stories where shorts are drawn to them. It means to me there is something there. If there weren’t, the boards would be dead. And there are plenty of very respectable companies where the bulletin boards have no interest and no shorts. And I also really dislike shorts.
It’s also one of the reasons I recognize old names from time to time like jondoeuk… an old shirt from the Yahoo boards. I think he used to post something like ocata’s stem cells have aids… but I could be confusing him with someone else.
I do think that it’s just part of the corporate experience that you have to maintain the percentage allocation for employees. Regardless of dilution. They did not “cause” dilution. Attacks and the complexity of the technology and regulatory process maybe are a cause, but that has nothing to do with the efforts of employees.
This is still, a pre-revenue, development stage company, not unlike private equity. One thing that always happens for the top group of investors and employees in such companies is anti-dilution clauses. You may not like it, but the solution is to do what private investors do in private equity to avoid dilution, keep buying in subsequent rounds. The difference here is that the subsequent rounds are not artificially set at higher and higher prices. You can still keep buying, sometimes at lower prices. Not everyone is going to do that or be in a position to do that. That’s just reality. It’s not a justification for punitive actions against these people who have dedicated their lives to this effort.
I respect your opinion but I heartily disagree as to the way to see this… and further, if it is properly authorized, I do not think it will now be rejected by the court. It was not previously put into place, so I suspect the lawsuit is now moot, if the resolution passes, though no doubt those suing will seek to keep it alive.
I never had a private message board. That is your fake story. I am on Twitter and here.
I recall you claiming that before and pointing to something not at all related to me. But yeah, you keep it up. Shows you really have no clue.
As for your claim of “true up”, the fact is, the law is quite tolerant of properly authorized allocations of equity. That’s the reality. The notion you create of a “true up”, suggesting that by sheer dint of the use of that term it is “illegal”, is false. As long as the allocation was properly authorized and transparent, the company, board and shareholders can do as they want, yes, even if they sought to true up the allocation that was originally intended for employees. As I said before, this is not the first company to allocate a certain target percentage of ownership to employees, and to want to ensure employees and yes board members and executives are properly rewarded and aligned with other shareholders, and it won’t be the last one. The fact that shorts targeted the company and are dedicated to screwing absolutely everyone, including the people who kept the company going, is to be expected. Malice is as malice does. Malicious behavior has been on show by these persons with their sideshows for so long now, with such immense dedication, that we will truly look forward to the full unmasking at the litigation and trial. It should be very interesting.
Since you’re admitting you trade and swing trade, your complaints are taken with a recognition that you’ll basically say anything to position for your next trade. You could be long gone, but here you are, an arsonist today and a cheerleader tomorrow.
Your message is very kindly received Tryn2. I actually spend very little time here these days, but when I pop in and see these guys posting their FUD, and knowing what we know about how hard fought this valiant effort has been, it is profoundly infuriating. Seeing such outright vandalism for greed, or for any reason, is so profoundly disillusioning. But also, it provokes a need for some response as letting it dominate the discussion will pull the ongoing discussion and view toward these deceptive and deceitful narratives.
I wish the company and all involved in this battle, always the best. We have all lost dear ones to center. I doubt there are any who haven’t, though clearly some losing loved ones who are closer than others. I feel they cannot go unanswered when they spread such deceptions and misinformation. Thank you again. It’s nice to hear and I appreciate you and all the other longs here as well who are also steadfast and remain for the good fight.
Unfortunately for the hedge fund naysayers, LP and LL will likely come out of this having many admirers for their steadfastness and inventiveness in the face of the worst, most awful forces trying to bring them and this company down. Since the naysayers are anonymous piggies, very unlikely anyone will sing their praises. They will be cast as the villains of the story, with their special praise singer, whom we all know.